Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News

The long-awaited psychedelic-assisted treatment alternative for Post-Traumatic Stress Disorder (PTSD) is moving closer to federal approval.  The Multidisciplinary Association for Psychedelic Studies (MAPS) and its private subsidiary company, MAPS PBC shared the publication of the results from the most advanced clinical trial (Phase 3 study) on MDMA-assisted therapy for the treatment of moderate-to-severe PTSD with solid, confirmatory […]

Peering Into Haleon’s Recent Short Interest

Haleon’s (NYSE:HLN) short percent of float has fallen 43.75% since its last report. The company recently reported that it has 12.63 million shares sold short, which is 0.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.71 days to cover their short positions on average. […]